rs5030721
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_138554.5(TLR4):c.1959G>A(p.Lys653Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,614,034 control chromosomes in the GnomAD database, including 117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0083 ( 7 hom., cov: 32)
Exomes 𝑓: 0.011 ( 110 hom. )
Consequence
TLR4
NM_138554.5 synonymous
NM_138554.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.391
Publications
9 publications found
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 9-117714087-G-A is Benign according to our data. Variant chr9-117714087-G-A is described in ClinVar as Benign. ClinVar VariationId is 786820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.391 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 7 gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TLR4 | NM_138554.5 | c.1959G>A | p.Lys653Lys | synonymous_variant | Exon 3 of 3 | ENST00000355622.8 | NP_612564.1 | |
| TLR4 | NM_003266.4 | c.1839G>A | p.Lys613Lys | synonymous_variant | Exon 4 of 4 | NP_003257.1 | ||
| TLR4 | NM_138557.3 | c.1359G>A | p.Lys453Lys | synonymous_variant | Exon 2 of 2 | NP_612567.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TLR4 | ENST00000355622.8 | c.1959G>A | p.Lys653Lys | synonymous_variant | Exon 3 of 3 | 1 | NM_138554.5 | ENSP00000363089.5 | ||
| ENSG00000285082 | ENST00000697666.1 | c.140+5358G>A | intron_variant | Intron 3 of 4 | ENSP00000513391.1 |
Frequencies
GnomAD3 genomes AF: 0.00829 AC: 1261AN: 152140Hom.: 7 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1261
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00896 AC: 2248AN: 250906 AF XY: 0.00960 show subpopulations
GnomAD2 exomes
AF:
AC:
2248
AN:
250906
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0112 AC: 16403AN: 1461776Hom.: 110 Cov.: 32 AF XY: 0.0112 AC XY: 8174AN XY: 727188 show subpopulations
GnomAD4 exome
AF:
AC:
16403
AN:
1461776
Hom.:
Cov.:
32
AF XY:
AC XY:
8174
AN XY:
727188
show subpopulations
African (AFR)
AF:
AC:
39
AN:
33476
American (AMR)
AF:
AC:
280
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
AC:
26
AN:
26134
East Asian (EAS)
AF:
AC:
4
AN:
39688
South Asian (SAS)
AF:
AC:
1129
AN:
86254
European-Finnish (FIN)
AF:
AC:
759
AN:
53384
Middle Eastern (MID)
AF:
AC:
34
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
13548
AN:
1111986
Other (OTH)
AF:
AC:
584
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1025
2050
3076
4101
5126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00828 AC: 1261AN: 152258Hom.: 7 Cov.: 32 AF XY: 0.00873 AC XY: 650AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
1261
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
650
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
76
AN:
41546
American (AMR)
AF:
AC:
105
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5172
South Asian (SAS)
AF:
AC:
57
AN:
4828
European-Finnish (FIN)
AF:
AC:
198
AN:
10606
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
806
AN:
68018
Other (OTH)
AF:
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
TLR4: BP4, BP7, BS1, BS2 -
Aug 21, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.